Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24010111
Abstract: Multiple myeloma (MM) is a plasma cell malignancy for which there is currently no cure. While treatment options for MM have expanded over the last two decades, all patients will eventually become resistant to current… read more here.
Keywords: biosynthetic pathway; multiple myeloma; isoprenoid biosynthetic; ibp inhibitors ... See more keywords